A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular anti-sense oligonucleotide activity

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-61039-y
Affiliations:
9
Authors:
17
Go to article
Institutions Authors Share
F. Hoffmann-La Roche Ltd., Switzerland
8.500000
 0.50
Genentech, Inc., United States of America (USA)
6.500000
 0.38
Roche Innovation Center Copenhagen A/S, Denmark
1.000000
 0.06
Biozentrum, UB, Switzerland
1.000000
 0.06
Interested in Medical Biotechnology?